article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing 257
article thumbnail

IVD Market: SWOT Analysis

Roots Analysis

Roots Analysis has conducted an exhaustive study on In Vitro Diagnostics Market featuring the current market landscape and future opportunity for the companies engaged in offering in vitro diagnostic solutions, over a span of 11 years. The figure pasted below shows a summarized representation of SWOT points affiliated with IVD Market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Retail Sales of Plant-Based Foods Surged to $7 Billion in 2020

XTalks

New data from the Plant Based Foods Association (PBFA) and The Good Food Institute (GFI) shows that the retail sales of plant-based foods in the US grew by 27 percent in 2020, bringing its total market value to $7 billion. of the $7 billion market. Plant-Based Milk Sales. Plant-Based Meat Sales. billion in sales in 2020.

Sales 98
article thumbnail

Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding

The Pharma Data

It has since expanded nationwide, threatening an important market for many Big Pharma players. . At the time, Wolfe Research analyst Tim Anderson wondered whether the decline was the “canary in the coalmine” for the rest of the industry, which has been relying on the lucrative China market for revenue growth.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

Jakub Hlávka, PhD, the executive director of the Healthcare Markets Initiative and Fellow at the University of Southern California Schaeffer Center, suggests the strategy behind this new warranty program could “minimise the [financial and clinical] risk for the provider and for the patient”.

Drugs 130
article thumbnail

BioSpace Movers & Shakers, Jan. 1

The Pharma Data

Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,

article thumbnail

Molecular Diagnostic Tests: The Unsung Hero of Precise Clinical Decision Making

Roots Analysis

It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market. According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market. To date, he has contributed to over eight full length market research projects and consulting projects.